
| June 28, 2025 | December 31, 2024 | |||||||||||||
| Assets | ||||||||||||||
| Current assets | ||||||||||||||
| Cash and cash equivalents | $ | 365,051 | $ | 196,589 | ||||||||||
Accounts receivable, net of allowances of $2,837 and $2,701, respectively | 169,766 | 278,582 | ||||||||||||
| Inventories, net | 228,292 | 216,472 | ||||||||||||
| Prepaid expenses | 18,859 | 20,203 | ||||||||||||
| Income tax receivable | — | 6,426 | ||||||||||||
| Other current assets | 48,688 | 48,697 | ||||||||||||
| Total current assets | 830,656 | 766,969 | ||||||||||||
Property, plant, and equipment, net of accumulated depreciation of $118,219 and $112,099, respectively | 154,931 | 160,377 | ||||||||||||
| Goodwill | 951,339 | 943,645 | ||||||||||||
| Trademark | 736,000 | 736,000 | ||||||||||||
| Customer relationships, net | 189,153 | 198,333 | ||||||||||||
| Other intangibles, net | 90,999 | 96,095 | ||||||||||||
| Other non-current assets | 83,998 | 89,205 | ||||||||||||
| Total assets | $ | 3,037,076 | $ | 2,990,624 | ||||||||||
Liabilities and Stockholders’ Equity | ||||||||||||||
| Current liabilities | ||||||||||||||
| Current portion of long-term debt | $ | 13,412 | $ | 13,991 | ||||||||||
| Accounts payable | 74,489 | 81,476 | ||||||||||||
| Accrued expenses and other liabilities | 198,751 | 217,242 | ||||||||||||
| Income taxes payable | 6,075 | 273 | ||||||||||||
| Total current liabilities | 292,727 | 312,982 | ||||||||||||
| Long-term debt, net | 949,064 | 950,562 | ||||||||||||
| Deferred tax liabilities, net | 234,060 | 239,111 | ||||||||||||
| Other non-current liabilities | 62,827 | 64,322 | ||||||||||||
| Total liabilities | 1,538,678 | 1,566,977 | ||||||||||||
Stockholders’ equity | ||||||||||||||
Preferred stock, $0.001 par value, 100,000,000 authorized, no shares issued or outstanding as of June 28, 2025 and December 31, 2024 | — | — | ||||||||||||
Common stock $0.001 par value, 750,000,000 authorized; 245,217,249 issued and 216,550,880 outstanding at June 28, 2025; 244,444,889 issued and 215,778,520 outstanding at December 31, 2024 | 246 | 245 | ||||||||||||
| Additional paid-in capital | 1,100,884 | 1,093,468 | ||||||||||||
Common stock in treasury; 28,666,369 and 28,666,369 at June 28, 2025 and December 31, 2024, respectively | (359,206) | (358,133) | ||||||||||||
| Retained earnings | 758,696 | 699,564 | ||||||||||||
| Accumulated other comprehensive income | (2,222) | (11,497) | ||||||||||||
Total stockholders’ equity | 1,498,398 | 1,423,647 | ||||||||||||
Total liabilities, redeemable stock, and stockholders’ equity | $ | 3,037,076 | $ | 2,990,624 | ||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
| June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | |||||||||||||||||||||||
| Net sales | $ | 299,603 | $ | 284,393 | $ | 528,444 | $ | 496,962 | ||||||||||||||||||
| Cost of sales | 141,764 | 139,306 | 257,230 | 247,296 | ||||||||||||||||||||||
| Gross profit | 157,839 | 145,087 | 271,214 | 249,666 | ||||||||||||||||||||||
| Selling, general and administrative expense | 71,893 | 63,155 | 137,010 | 123,169 | ||||||||||||||||||||||
| Research, development and engineering expense | 6,128 | 6,119 | 12,114 | 12,421 | ||||||||||||||||||||||
| Acquisition and restructuring related expense | 1,565 | 839 | 3,491 | 1,343 | ||||||||||||||||||||||
| Amortization of intangible assets | 6,870 | 6,949 | 13,705 | 13,849 | ||||||||||||||||||||||
| Operating income | 71,383 | 68,025 | 104,894 | 98,884 | ||||||||||||||||||||||
| Interest expense, net | 13,650 | 16,799 | 27,301 | 35,391 | ||||||||||||||||||||||
| Loss on debt extinguishment | — | 4,926 | — | 4,926 | ||||||||||||||||||||||
| Other expense (income), net | (1,706) | (646) | (527) | (1,284) | ||||||||||||||||||||||
| Total other expense | 11,944 | 21,079 | 26,774 | 39,033 | ||||||||||||||||||||||
| Income from operations before income taxes | 59,439 | 46,946 | 78,120 | 59,851 | ||||||||||||||||||||||
| Provision for income taxes | 14,640 | 9,365 | 18,988 | 12,430 | ||||||||||||||||||||||
| Net income | $ | 44,799 | $ | 37,581 | $ | 59,132 | $ | 47,421 | ||||||||||||||||||
| Earnings per share | ||||||||||||||||||||||||||
| Basic | $ | 0.21 | $ | 0.17 | $ | 0.27 | $ | 0.22 | ||||||||||||||||||
| Diluted | $ | 0.20 | $ | 0.17 | $ | 0.27 | $ | 0.21 | ||||||||||||||||||
| Weighted average common shares outstanding | ||||||||||||||||||||||||||
| Basic | 216,382,177 | 214,915,338 | 216,175,618 | 214,637,930 | ||||||||||||||||||||||
| Diluted | 221,834,188 | 221,259,232 | 221,856,056 | 221,159,419 | ||||||||||||||||||||||
Hayward Holdings, Inc. Unaudited Condensed Consolidated Statements of Cash Flows (In thousands) | Six Months Ended | |||||||||||||
| June 28, 2025 | June 29, 2024 | |||||||||||||
| Cash flows from operating activities | ||||||||||||||
| Net income | $ | 59,132 | $ | 47,421 | ||||||||||
| Adjustments to reconcile net income to net cash used in operating activities | ||||||||||||||
| Depreciation | 11,517 | 9,067 | ||||||||||||
| Amortization of intangible assets | 17,166 | 17,046 | ||||||||||||
| Amortization of deferred debt issuance fees | 1,880 | 2,294 | ||||||||||||
| Stock-based compensation | 6,317 | 4,632 | ||||||||||||
| Deferred income taxes | (3,008) | (6,631) | ||||||||||||
| Allowance for bad debts | 2 | 81 | ||||||||||||
| Loss on debt extinguishment | — | 4,926 | ||||||||||||
| (Gain) loss on sale of property, plant and equipment | 206 | (504) | ||||||||||||
| Changes in operating assets and liabilities | ||||||||||||||
| Accounts receivable | 114,267 | 124,537 | ||||||||||||
| Inventories | (6,098) | 6,384 | ||||||||||||
| Other current and non-current assets | 6,176 | 7,803 | ||||||||||||
| Accounts payable | (8,321) | (562) | ||||||||||||
| Accrued expenses and other liabilities | (10,874) | (6,655) | ||||||||||||
| Net cash provided by operating activities | 188,362 | 209,839 | ||||||||||||
| Cash flows from investing activities | ||||||||||||||
| Purchases of property, plant, and equipment | (12,423) | (9,685) | ||||||||||||
| Software development costs | (1,159) | (1,021) | ||||||||||||
| Acquisitions, net of cash acquired | — | (62,367) | ||||||||||||
| Proceeds from sale of property, plant, and equipment | — | 48 | ||||||||||||
| Proceeds from short-term investments | — | 25,000 | ||||||||||||
| Net cash used in investing activities | (13,582) | (48,025) | ||||||||||||
| Cash flows from financing activities | ||||||||||||||
| Proceeds from issuance of long-term debt | — | 2,856 | ||||||||||||
| Payments of long-term debt | (3,831) | (129,401) | ||||||||||||
| Proceeds from issuance of short-term notes payable | — | 6,340 | ||||||||||||
| Payments of short-term notes payable | (2,169) | (2,888) | ||||||||||||
| Debt issuance costs | (1,143) | — | ||||||||||||
| Purchase of common stock | (1,073) | (355) | ||||||||||||
| Other, net | 164 | (159) | ||||||||||||
| Net cash used in financing activities | (8,052) | (123,607) | ||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | 1,734 | (1,248) | ||||||||||||
| Change in cash and cash equivalents | 168,462 | 36,959 | ||||||||||||
| Cash and cash equivalents, beginning of period | 196,589 | 178,097 | ||||||||||||
| Cash and cash equivalents, end of period | $ | 365,051 | $ | 215,056 | ||||||||||
| Supplemental disclosures of cash flow information: | ||||||||||||||
| Cash paid-interest | $ | 25,230 | $ | 36,601 | ||||||||||
| Cash paid-income taxes | 9,591 | 6,221 | ||||||||||||
| Non-cash investing and financing activities: | ||||||||||||||
| Accrued and unpaid purchases of property, plant, and equipment | $ | 927 | $ | 600 | ||||||||||
| Equipment financed under finance leases | 344 | 630 | ||||||||||||
| (Dollars in thousands) | Three Months Ended | Six Months Ended | ||||||||||||||||||||||||
| June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | |||||||||||||||||||||||
| Net income | $ | 44,799 | $ | 37,581 | $ | 59,132 | $ | 47,421 | ||||||||||||||||||
| Depreciation | 5,254 | 4,757 | 11,517 | 9,067 | ||||||||||||||||||||||
| Amortization | 8,631 | 8,503 | 17,166 | 17,046 | ||||||||||||||||||||||
| Interest expense, net | 13,650 | 16,799 | 27,301 | 35,391 | ||||||||||||||||||||||
| Income taxes | 14,640 | 9,365 | 18,988 | 12,430 | ||||||||||||||||||||||
| Loss on debt extinguishment | — | 4,926 | — | 4,926 | ||||||||||||||||||||||
| EBITDA | 86,974 | 81,931 | 134,104 | 126,281 | ||||||||||||||||||||||
Stock-based compensation (a) | 11 | 230 | 57 | 420 | ||||||||||||||||||||||
Currency exchange items (b) | 778 | (180) | 772 | (126) | ||||||||||||||||||||||
Acquisition and restructuring related expense, net (c) | 1,565 | 839 | 3,491 | 1,343 | ||||||||||||||||||||||
Other (d) | (1,092) | (206) | (1,086) | (263) | ||||||||||||||||||||||
| Total Adjustments | 1,262 | 683 | 3,234 | 1,374 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 88,236 | $ | 82,614 | $ | 137,338 | $ | 127,655 | ||||||||||||||||||
| Net income margin | 15.0 | % | 13.2 | % | 11.2 | % | 9.5 | % | ||||||||||||||||||
| Adjusted EBITDA margin | 29.5 | % | 29.0 | % | 26.0 | % | 25.7 | % | ||||||||||||||||||
| (a) | Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of Hayward’s initial public offering (the “IPO”). | |||||||
| (b) | Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts. | |||||||
| (c) | Adjustments in the three months ended June 28, 2025 are primarily driven by $1.5 million of transaction and integration costs associated with the acquisition of ChlorKing HoldCo, LLC and related entities (“ChlorKing”) and $0.2 million of termination benefits related to a reduction-in-force within E&RW, partially offset by a reduction in expense of $0.2 million to finalize the relocation of the Company's corporate office functions to Charlotte, North Carolina from Berkeley Heights, New Jersey. Adjustments in the three months ended June 29, 2024 are primarily driven by $0.6 million of transaction costs associated with the acquisition of the ChlorKing business and $0.3 million of separation and other costs associated with the centralization of operations in Europe. Adjustments in the six months ended June 28, 2025 are primarily driven by $3.3 million of transaction and integration costs associated with the acquisition of the ChlorKing business, $0.2 million of separation costs for the consolidation of operations in North America and $0.2 million of termination benefits related to a reduction-in-force within E&RW, partially offset by a reduction in expense of $0.2 million to finalize the relocation of the Company's corporate office functions to Charlotte, North Carolina from Berkeley Heights, New Jersey. Adjustments in the six months ended June 29, 2024 are primarily driven by $0.7 million of separation and other costs associated with the centralization of operations in Europe and $0.6 million of transaction costs associated with the acquisition of ChlorKing. | |||||||
| (d) | Adjustments in the three months ended June 28, 2025 primarily include $1.1 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the three months ended June 29, 2024 are primarily driven by $0.5 million of gains on the sale of assets, partially offset by $0.2 million of costs incurred related to litigation. Adjustments in the six months ended June 28, 2025 primarily include $1.1 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the six months ended June 29, 2024 are primarily driven by $0.5 million of gains on the sale of assets, partially offset by $0.3 million of costs incurred related to litigation. | |||||||
| (Dollars in thousands) | Last Twelve Months(e) | Fiscal Year | ||||||||||||
| June 28, 2025 | December 31, 2024 | |||||||||||||
| Net income | $ | 130,366 | $ | 118,655 | ||||||||||
| Depreciation | 22,528 | 20,078 | ||||||||||||
| Amortization | 35,903 | 35,783 | ||||||||||||
| Interest expense, net | 54,073 | 62,163 | ||||||||||||
| Income taxes | 32,085 | 25,527 | ||||||||||||
| Loss on debt extinguishment | — | 4,926 | ||||||||||||
| EBITDA | 274,955 | 267,132 | ||||||||||||
Stock-based compensation (a) | 245 | 608 | ||||||||||||
Currency exchange items (b) | 62 | (836) | ||||||||||||
Acquisition and restructuring related expense, net (c) | 8,612 | 6,464 | ||||||||||||
Other (d) | 3,256 | 4,079 | ||||||||||||
| Total Adjustments | 12,175 | 10,315 | ||||||||||||
| Adjusted EBITDA | $ | 287,130 | $ | 277,447 | ||||||||||
| Net income margin | 12.0 | % | 11.3 | % | ||||||||||
| Adjusted EBITDA margin | 26.5 | % | 26.4 | % | ||||||||||
| (a) | Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of the IPO. | |||||||
| (b) | Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts. | |||||||
| (c) | Adjustments in the last twelve months ended June 28, 2025 primarily include $6.3 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition. Pursuant to the ChlorKing acquisition agreement, this $6.3 million was an employee retention payment that was deposited into an escrow account on the date of acquisition. The full amount held in escrow was to be released to the specified key employees if such employees are employed by Hayward on the one-year anniversary of the acquisition. These payments were contingent on continued employment and are not dependent on the achievement of any metric or performance measure. The retention costs will be recognized over the twelve-month period from the date of acquisition. Further, other adjustments include $1.0 million of termination benefits related to a reduction-in-force within E&RW, $0.7 million of transaction and integration costs associated with the acquisition of the ChlorKing business, $0.4 million of costs to finalize restructuring actions initiated in prior years and $0.2 million of separation costs associated with the consolidation of operations in North America. Adjustments in the year ended December 31, 2024 are primarily driven by $3.2 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition. Pursuant to the ChlorKing acquisition agreement, this $3.2 million was part of a total $6.3 million employee retention payment that was deposited into an escrow account on the date of acquisition. The full amount held in escrow will be released to the specified key employees if such employees are employed by Hayward on the one-year anniversary of the acquisition. These payments are contingent on continued employment and are not dependent on the achievement of any metric or performance measure. The retention costs will be recognized over the twelve-month period from the date of acquisition. Further, other adjustments for the year ended December 31, 2024 include $1.1 million of transaction and integration costs associated with the acquisition of the ChlorKing business, $0.9 million of termination benefits related to a reduction-in-force within E&RW, $0.8 million of separation and other costs associated with the centralization and consolidation of operations in Europe and $0.4 million of costs to finalize restructuring actions initiated in prior years. | |||||||
| (d) | Adjustments in the last twelve months ended June 28, 2025 are primarily driven by a $3.3 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business, $0.7 million in costs incurred as a result of flood damage from a hurricance at a contract manufacturing facility, and $0.3 million of costs incurred related to litigation, partially offset by $1.1 million of insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the year ended December 31, 2024 are primarily driven by a $3.3 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business, $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility and $0.5 million of costs incurred related to litigation, partially offset by $0.5 million of gains on the sale of assets. | |||||||
| (e) | Items for the last twelve months ended June 28, 2025 are calculated by adding the items for the six months ended June 28, 2025 plus fiscal year ended December 31, 2024 and subtracting the items for the six months ended June 29, 2024. | |||||||
(Dollars in thousands, except per share data) | Three Months Ended | Six Months Ended | ||||||||||||||||||||||||
| June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | |||||||||||||||||||||||
| Net income | $ | 44,799 | $ | 37,581 | $ | 59,132 | $ | 47,421 | ||||||||||||||||||
Tax adjustments (a) | (9) | (1,624) | (192) | (1,771) | ||||||||||||||||||||||
| Other adjustments and amortization: | ||||||||||||||||||||||||||
Stock-based compensation (b) | 11 | 230 | 57 | 420 | ||||||||||||||||||||||
Currency exchange items (c) | 778 | (180) | 772 | (126) | ||||||||||||||||||||||
Acquisition and restructuring related expense, net (d) | 1,565 | 839 | 3,491 | 1,343 | ||||||||||||||||||||||
Other (e) | (1,092) | (206) | (1,086) | (263) | ||||||||||||||||||||||
| Total other adjustments | 1,262 | 683 | 3,234 | 1,374 | ||||||||||||||||||||||
| Loss on debt extinguishment | — | 4,926 | — | 4,926 | ||||||||||||||||||||||
| Amortization | 8,631 | 8,503 | 17,166 | 17,046 | ||||||||||||||||||||||
Tax effect (f) | (2,438) | (3,304) | (5,008) | (5,539) | ||||||||||||||||||||||
| Adjusted net income | $ | 52,245 | $ | 46,765 | $ | 74,332 | $ | 63,457 | ||||||||||||||||||
| Weighted average number of common shares outstanding, basic | 216,382,177 | 214,915,338 | 216,175,618 | 214,637,930 | ||||||||||||||||||||||
| Weighted average number of common shares outstanding, diluted | 221,834,188 | 221,259,232 | 221,856,056 | 221,159,419 | ||||||||||||||||||||||
| Basic EPS | $ | 0.21 | $ | 0.17 | $ | 0.27 | $ | 0.22 | ||||||||||||||||||
| Diluted EPS | $ | 0.20 | $ | 0.17 | $ | 0.27 | $ | 0.21 | ||||||||||||||||||
| Adjusted basic EPS | $ | 0.24 | $ | 0.22 | $ | 0.34 | $ | 0.30 | ||||||||||||||||||
| Adjusted diluted EPS | $ | 0.24 | $ | 0.21 | $ | 0.34 | $ | 0.29 | ||||||||||||||||||
| (a) | Tax adjustments for the three and six months ended June 28, 2025 reflect a normalized tax rate of 24.6% and 24.6%, respectively, compared to the Company’s effective tax rate of 24.6% and 24.3%, respectively. The Company’s effective tax rate for the three and six months ended June 28, 2025 primarily includes the tax benefits resulting from stock compensation. Tax adjustments for the three and six months ended June 29, 2024 reflect a normalized tax rate of 23.4% and 23.7%, respectively, compared to the Company's effective tax rate of 19.9% and 20.8%, respectively. The Company’s effective tax rate for the three months ended June 29, 2024 includes the tax benefits resulting from stock compensation and the six months ended June 29, 2024 additionally include a tax benefit resulting from a return-to-provision adjustment. | |||||||
| (b) | Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of the IPO. | |||||||
| (c) | Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts. | |||||||
| (d) | Adjustments in the three months ended June 28, 2025 are primarily driven by $1.5 million of transaction and integration costs associated with the acquisition of ChlorKing and $0.2 million of termination benefits related to a reduction-in-force within E&RW, partially offset by a reduction in expense of $0.2 million to finalize the relocation of the Company's corporate office functions to Charlotte, North Carolina from Berkeley Heights, New Jersey. Adjustments in the three months ended June 29, 2024 are primarily driven by $0.6 million of transaction costs associated with the acquisition of the ChlorKing business and $0.3 million of separation and other costs associated with the centralization of operations in Europe. Adjustments in the six months ended June 28, 2025 are primarily driven by $3.3 million of transaction and integration costs associated with the acquisition of the ChlorKing business, $0.2 million of separation costs for the consolidation of operations in North America and $0.2 million of termination benefits related to a reduction-in-force within E&RW, partially offset by a reduction in expense of $0.2 million to finalize the relocation of the Company's corporate office functions to Charlotte, North Carolina from Berkeley Heights, New Jersey. Adjustments in the six months ended June 29, 2024 are primarily driven by $0.7 million of separation and other costs associated with the centralization of operations in Europe and $0.6 million of transaction costs associated with the acquisition of ChlorKing. | |||||||
| (e) | Adjustments in the three months ended June 28, 2025 primarily include $1.1 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the three months ended June 29, 2024 are primarily driven by $0.5 million of gains on the sale of assets, partially offset by $0.2 million of costs incurred related to litigation. Adjustments in the six months ended June 28, 2025 primarily include $1.1 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the six months ended June 29, 2024 are primarily driven by $0.5 million of gains on the sale of assets, partially offset by $0.3 million of costs incurred related to litigation. | |||||||
| (f) | The tax effect represents the immediately preceding adjustments at the normalized tax rates as discussed in footnote (a) above. | |||||||
| (Dollars in thousands) | Three Months Ended | Three Months Ended | |||||||||||||||||||||||||||
| June 28, 2025 | June 29, 2024 | ||||||||||||||||||||||||||||
| NAM | E&RW | NAM | E&RW | ||||||||||||||||||||||||||
| Segment income | $ | 83,374 | $ | 7,589 | $ | 75,335 | $ | 8,289 | |||||||||||||||||||||
| Depreciation | 4,448 | 439 | $ | 4,328 | $ | 263 | |||||||||||||||||||||||
| Amortization | 1,761 | — | 1,554 | — | |||||||||||||||||||||||||
| Stock-based compensation | — | — | 57 | — | |||||||||||||||||||||||||
Other (a) | (513) | — | — | — | |||||||||||||||||||||||||
| Total adjustments | 5,696 | 439 | 5,939 | 263 | |||||||||||||||||||||||||
| Adjusted segment income | $ | 89,070 | $ | 8,028 | $ | 81,274 | $ | 8,552 | |||||||||||||||||||||
| Segment income margin % | 32.7 | % | 17.1 | % | 31.2 | % | 19.2 | % | |||||||||||||||||||||
| Adjusted segment income margin % | 34.9 | % | 18.1 | % | 33.7 | % | 19.8 | % | |||||||||||||||||||||
| (a) | The three months ended June 28, 2025 primarily includes $0.5 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. | |||||||
| (Dollars in thousands) | Six Months Ended | Six Months Ended | ||||||||||||||||||||||||
| June 28, 2025 | June 29, 2024 | |||||||||||||||||||||||||
| NAM | E&RW | NAM | E&RW | |||||||||||||||||||||||
| Segment income | $ | 126,828 | $ | 14,127 | $ | 115,077 | $ | 14,325 | ||||||||||||||||||
| Depreciation | 9,948 | 853 | $ | 8,215 | $ | 520 | ||||||||||||||||||||
| Amortization | 3,461 | — | 3,197 | — | ||||||||||||||||||||||
| Stock-based compensation | — | — | 69 | 10 | ||||||||||||||||||||||
Other (a) | (510) | — | 19 | — | ||||||||||||||||||||||
| Total adjustments | 12,899 | 853 | 11,500 | 530 | ||||||||||||||||||||||
Adjusted segment income | $ | 139,727 | $ | 14,980 | $ | 126,577 | $ | 14,855 | ||||||||||||||||||
| Segment income margin % | 28.7 | % | 16.4 | % | 27.8 | % | 17.4 | % | ||||||||||||||||||
Adjusted segment income margin % | 31.6 | % | 17.4 | % | 30.5 | % | 18.0 | % | ||||||||||||||||||
| (a) | The six months ended June 28, 2025 primarily includes $0.5 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. The six months ended June 29, 2024 represents losses on the sale of assets. | |||||||